About Red Nucleus
Red Nucleus is a company based in Yardley (United States) founded in 2014 was acquired by Thomas H Lee Partners in October 2024. Red Nucleus has completed 11 acquisitions, including Actando, Bridge Medical and COEUS. Red Nucleus offers products and services including DirectusPRO, iTakeControl, Partner Vault, Red Nucleus Training Institute, and UNIFY. Red Nucleus operates in a competitive market with competitors including Eurofins Scientific, WuXi AppTec, Ipsen, CHEPLAPHARM and ANI Pharmaceuticals, among others.
- Headquarter Yardley, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Red Nucleus Solutions Llc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Thomas H Lee Partners
& 2 more
-
Employee Count
Not available
-
Investments & Acquisitions
Actando
& 10 more
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Red Nucleus
Red Nucleus offers a comprehensive portfolio of products and services, including DirectusPRO, iTakeControl, Partner Vault, Red Nucleus Training Institute, and UNIFY.
Platform for managing scientific and advisory services in life sciences.
Tool for interactive learning and development in healthcare contexts.
System for secure storage and access to partner resources.
Institute providing training solutions for life sciences professionals.
Platform unifying game-based learning for healthcare applications.
Lab for creating interactive games to enhance medical education.
People of Red Nucleus
Unlock access to complete
Unlock access to complete
Funding Insights of Red Nucleus
Investors in Red Nucleus
Red Nucleus has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Thomas H Lee Partners, Renovus Capital Partners and The Riverside Company.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Private equity and debt are provided to middle market companies.
|
Locked | Locked | Locked | |
|
Private equity investments are directed toward traditional industries.
|
Locked | Locked | Locked |
Investor details for Red Nucleus
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Red Nucleus
Red Nucleus has strategically engaged in corporate development activities, having acquired 11 companies. Notable acquisitions include Actando, Bridge Medical and COEUS.
Investment portfolio details for Red Nucleus
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Content creation and market research services are provided to clients.
|
Locked | Locked | 2019 | Locked | |
|
Business strategy consulting services are provided to clients.
|
Locked | Locked | 2017 | Locked | |
|
Market access and strategy services are provided for pharmaceuticals.
|
Locked | Locked | 2015 | Locked |
Complete acquisition details for Red Nucleus
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Red Nucleus
Detailed financials for Red Nucleus
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Red Nucleus Comparisons
Peer comparison for Red Nucleus
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Red Nucleus
Red Nucleus operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Eurofins Scientific, WuXi AppTec, Ipsen, CHEPLAPHARM and ANI Pharmaceuticals, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Laboratory testing and contract research services are provided globally.
|
|
| Locked | Locked | Locked |
Provider of CRO and CDMO services
|
|
| Locked | Locked | Locked |
Biopharmaceutical company focused on developing and commercializing innovative treatments in oncology, rare disease, and neuroscience to improve patient health outcomes
|
|
| Locked | Locked | Locked |
Branded pharmaceutical products are developed, marketed, and distributed globally.
|
|
| Locked | Locked | Locked |
Branded and generic prescription drugs are developed, manufactured, and marketed.
|
|
| Locked | Locked | Locked |
CRO focused on clinical development for phases II & III clinical trials and regulatory affair services
|
Detailed competitors of Red Nucleus
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Red Nucleus
Complete news archive for Red Nucleus
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Red Nucleus
Red Nucleus was founded in 2014 and raised its 1st funding round 2 years after it was founded.
Red Nucleus is headquartered in Yardley, United States. It is registered at Yardley, Pennsylvania, United States.
Ian Kelly is the current CEO of Red Nucleus.
Red Nucleus was founded in 2014 and is based in Yardley, United States. Services are offered in advisory, scientific, and medical communications within the pharmaceutical and biotech sectors. Subject matter experts are provided in areas such as quality, clinical, safety, regulatory, and medical affairs. Operations focus on delivering insights, efficiencies, and support to shape value, navigate market access, and optimize pricing for innovators aiming to enhance health outcomes.
Red Nucleus's top competitors include WuXi AppTec, ANI Pharmaceuticals and Aptar.
Red Nucleus offers DirectusPRO, iTakeControl, Partner Vault, Red Nucleus Training Institute, and 2 more products and services.
Red Nucleus has made 11 acquisitions, including Actando, Bridge Medical, and COEUS.
Red Nucleus has 3 investors. Key investors include Thomas H Lee Partners, Renovus Capital Partners, and The Riverside Company.